| Titolo |
Pubblicato in |
Anno |
| Molecular mechanisms of naringenin modulation of mitochondrial permeability transition acting on F1FO-ATPase and counteracting saline load-induced injury in SHRSP cerebral endothelial cells |
EUROPEAN JOURNAL OF CELL BIOLOGY |
2024 |
| Disentangling multiple sclerosis phenotypes through Mendelian disorders: A network approach |
MULTIPLE SCLEROSIS |
2024 |
| Gut Microbiota Composition Is Causally Linked to Multiple Sclerosis: A Mendelian Randomization Analysis |
MICROORGANISMS |
2024 |
| FGFR2c Upregulation Contributes to Cancer-Associated Fibroblast Program Activation and to Enhanced Autophagy in Actinic Keratosis-Derived Dermal Fibroblasts: A Possible Role in Precancerous Cell/Stromal Cell Crosstalk |
BIOLOGY |
2023 |
| Multiple sclerosis genetic and non-genetic factors interact through the transient transcriptome |
SCIENTIFIC REPORTS |
2022 |
| Late-Onset MS: Disease Course and Safety-Efficacy of DMTS |
FRONTIERS IN NEUROLOGY |
2022 |
| Exosome-Encased Nucleic Acid Scaffold Chemotherapeutic Agents for Superior Anti-Tumor and Anti-Angiogenesis Activity |
ACS BIO & MED CHEM AU |
2022 |
| Mait cells and microbiota in multiple sclerosis and other autoimmune diseases |
MICROORGANISMS |
2021 |
| A case of double standard. Sex differences in multiple sclerosis risk factors |
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES |
2021 |
| Multiple Sclerosis and SARS-CoV-2: Has the Interplay Started? |
FRONTIERS IN IMMUNOLOGY |
2021 |
| Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapies |
EBIOMEDICINE |
2021 |
| Enrichment analysis of GWAS data in autoimmunity delineates the multiple sclerosis-Epstein Barr virus association |
biorXiv |
2021 |
| Reworking GWAS data to understand the role of nongenetic factors in MS etiopathogenesis |
GENES |
2020 |
| SARS-CoV-2 meta-interactome suggests disease-specific, autoimmune pathophysiologies and therapeutic targets |
F1000RESEARCH |
2020 |
| Kinome profiling of non-Hodgkin lymphoma identifies Tyro3 as a therapeutic target in primary effusion lymphoma |
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA |
2019 |
| Targeting mTOR with MLN0128 Overcomes Rapamycin and Chemoresistant Primary Effusion Lymphoma |
MBIO |
2019 |
| Extracellular vesicles from Kaposi Sarcoma-associated herpesvirus lymphoma induce long-term endothelial cell reprogramming |
PLOS PATHOGENS |
2019 |
| Kaposi's Sarcoma-Associated Herpesvirus Latency Locus Renders B Cells Hyperresponsive to Secondary Infections |
JOURNAL OF VIROLOGY |
2018 |
| Epstein-Barr virus enhances genome maintenance of Kaposi sarcoma-associated herpesvirus |
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA |
2018 |
| Antimicrobial sulfonamides clear latent Kaposi sarcoma herpesvirus infection and impair MDM2-p53 complex formation |
JOURNAL OF ANTIBIOTICS |
2017 |
